9 completed, 4 unknown, 1 active not recruiting. 14 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 14 | Completed 9, Unknown 4, Active not recruiting 1 |
Follow HIV Seropositivity: new trials by email Literature Review of HIV Seropositivity trials Research Report on HIV Seropositivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients Daily rifapentine and isoniazid for 4 weeks, Weekly rifapentine and isoniazid for 12 weeks - HIV Seropositivity, Tuberculosis | Phase 4 | Active not recruiting | The Aurum Institute NPC | 1000 | 2023-07-19 | 2025-12-12 |
| Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant BIC/F/TAF 50Mg-200Mg-25Mg Tablet - HIV Infections, Renal Transplant Rejection | Phase 4 | Completed | Weill Medical College of Cornell University | 20 | 2020-11-09 | 2025-08-12 |
| Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST Biktarvy arm - HIV Seropositivity | Phase 4 | Unknown | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 110 | 2019-11-18 | 2020-01-09 |
| Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir Raltegravir - HIV Seropositivity, Metabolic Syndrome | Phase 4 | Completed | Helsinki University Central Hospital | 45 | 2018-01-10 | 2021-09-05 |
| Alcohol Research Consortium in HIV-Intervention Research Arm Computerized Brief Intervention (CBI), CBT4CBT, Recommendation and Counseling for Alcohol Pharmacotherapy - HIV Positive, Alcohol Use | Phase 4 | Completed | University of Alabama at Birmingham | 4985 | 2017-11-06 | 2025-03-10 |
| IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children ZDV+3TC+LPV/r - HIV Positive, Malnourished | Phase 4 | Completed | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 52 | 2015-10-26 | 2021-08-12 |
| Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects darunavir/cobicistat, rilpivirine - HIV Positive | Phase 4 | Unknown | Therapeutic Concepts | 30 | 2015-03-01 | 2015-03-31 |
| IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi. Injectable polio vaccine and Bivalent oral polio vaccine - Immunity to Polio Vaccines in Malnourished Infants, Immunity to Polio Vaccines in Non-malnourished Infants | Phase 4 | Completed | Aga Khan University | 840 | 2012-10-01 | 2014-01-16 |
| Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients AdimFlu-S - Influenza | Phase 4 | Unknown | National Cheng-Kung University Hospital | 300 | 2011-10-01 | 2012-01-19 |
| Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB TDF, Stop TDF - Chronic Hepatitis B | Phase 4 | Completed | Gilead Sciences | 43 | 2011-04-26 | 2017-08-29 |
| A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy maraviroc in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor), maraviroc plus raltegravir in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor), efavirenz [or other NNRTI (non-nucleoside reverse transcriptase inhibitor)] - HIV Infections | Phase 4 | Completed | University of California, Davis | 44 | 2009-04-01 | 2017-05-30 |
| Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus cyclosporine and sodium carboximethycellulose, sodium carboximethycellulose - Dry Eye Syndromes, HIV Seropositivity | Phase 4 | Unknown | Universidade Federal do Rio de Janeiro | 20 | 2006-10-01 | 2008-11-24 |
| Effect of Genetics on Metabolism of Efavirenz Blood draw - Metabolism | Phase 4 | Completed | National Institutes of Health Clinical Center (CC) | 350 | 2005-10-18 | 2017-07-02 |
| Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia Sulfadoxine-pyrimethamine (Fansidar) - Placental Malaria Infection, HIV Infections | Phase 4 | Completed | Center for International Health and Development | 454 | 2002-11-01 | 2006-01-31 |
HIV Infections (3) · Malnutrition (2) · Alcohol Drinking (1) · Dry Eye Syndromes (1) · Fatty Liver (1) · Hepatitis B, Chronic (1) · Influenza, Human (1) · Malaria (1) · Malaria, Falciparum (1) · Metabolic Syndrome (1) · Perinatal Death (1) · Placenta Diseases (1) · Poliomyelitis (1) · Premature Birth (1)
Blood-Borne Infections (14) · Communicable Diseases (14) · Genital Diseases (14) · Immune System Diseases (14) · Immunologic Deficiency Syndromes (14) · Infections (14) · Lentivirus Infections (14) · RNA Virus Infections (14) · Retroviridae Infections (14) · Sexually Transmitted Diseases (14) · Sexually Transmitted Diseases, Viral (14) · Urogenital Diseases (14) · Virus Diseases (14) · HIV Infections (11) · Nutritional and Metabolic Diseases (3)
Raltegravir Potassium (2) · APT (1) · Blood Specimen Collection (1) · Cognitive Behavioral Therapy (1) · Counseling (1) · Cyclosporine (1) · Ethanol (1) · Isoniazid (1) · Lamivudine (1) · Lopinavir (1) · Maraviroc (1) · Rilpivirine (1) · Tenofovir (1) · Zidovudine (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)
Aga Khan University (1) · Center for International Health and Development (1) · Gilead Sciences (1) · Helsinki University Central Hospital (1) · Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba (1) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1) · National Cheng-Kung University Hospital (1) · National Institutes of Health Clinical Center (CC) (1) · The Aurum Institute NPC (1) · Therapeutic Concepts (1) · Universidade Federal do Rio de Janeiro (1) · University of Alabama at Birmingham (1) · University of California, Davis (1) · Weill Medical College of Cornell University (1)
United States (5) · Brazil (1) · Finland (1) · France (1) · Germany (1) · India (1) · Indonesia (1) · Malawi (1) · Mozambique (1) · Pakistan (1) · South Africa (1) · Taiwan (1) · Tanzania (1) · Uganda (1) · Zambia (1)
Ali F Saleem, MBBS, MCR, FCPS (1) · Anita K.M Zaidi, MBBS, SM (1) · Catherine B Small, MD (1) · David M. Asmuth, MD (1) · Davidson H Hamer, MD (1) · Farheen Quadri, MBBS, MSCR (1) · Gavin Churchyard (1) · Joseph C. Gathe, Jr., MD (1) · Jussi Sutinen, MD PhD (1) · Maxensia O Owor, MBChB, MMED, MPH (1) · Rodrigo P Barreto, Masters (1)
PMID 18008241, PMID 21436711, PMID 27015639, PMID 28736139, PMID 28968888, PMID 29788075, PMID 33464021, PMID 34524919, PMID 36541643, PMID 37919816, PMID 39324693
U01AI068632 (1)